Enhancing liver fibrosis diagnosis and treatment assessment: a novel biomechanical markers-based machine learning approach

Phys Med Biol. 2024 May 30;69(11). doi: 10.1088/1361-6560/ad4c4e.

Abstract

Accurate diagnosis and treatment assessment of liver fibrosis face significant challenges, including inherent limitations in current techniques like sampling errors and inter-observer variability. Addressing this, our study introduces a novel machine learning (ML) framework, which integrates light gradient boosting machine and multivariate imputation by chained equations to enhance liver status assessment using biomechanical markers. Building upon our previously established multiscale mechanical characteristics in fibrotic and treated livers, this framework employs Gaussian Bayesian optimization for post-imputation, significantly improving classification performance. Our findings indicate a marked increase in the precision of liver fibrosis diagnosis and provide a novel, quantitative approach for assessing fibrosis treatment. This innovative combination of multiscale biomechanical markers with advanced ML algorithms represents a transformative step in liver disease diagnostics and treatment evaluation, with potential implications for other areas in medical diagnostics.

Keywords: biomechanical marker; light gradient boosting machine (LightGBM); liver fibrosis; machine learning (ML); multivariate imputation by chained equations (MICE).

MeSH terms

  • Animals
  • Bayes Theorem
  • Biomarkers / metabolism
  • Biomechanical Phenomena
  • Humans
  • Liver Cirrhosis*
  • Machine Learning*
  • Mechanical Phenomena

Substances

  • Biomarkers